The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
A major push to sharpen the future of cancer treatment is underway
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
A brand from Opella will be part of the official NASA astronaut formulary
The campaign builds on the three-year partnership unveiled earlier this season
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
Subscribe To Our Newsletter & Stay Updated